Prognostic value of immunohistochemical marker HER2/neu in patients resected for gastric cancer stage IIIA
Introduction Patients with the same stage of malignancy often have different life-span, which makes it necessary to search for new prognostic factors. The high incidence and low survival rate of patients with gastric cancer also cause an increased interest in studying the immunohistochemical p...
Saved in:
| Main Author: | O. M. Levyk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2014-04-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/25417/22907 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Immunohistochemical Study in Urothelial Carcinoma of HER2/neu in Iraqi Patients
by: Athraa Falah Alshimerry
Published: (2025-01-01) -
Histopathological Study of Gastric Adenocarcinoma with Special Reference to Expression of HER2/neu and Ki-67 Assessed by Immunohistochemistry
by: Saiqa Nisar, et al.
Published: (2024-10-01) -
A case of pathological complete regression in combined modality treatment of resectable Her2/neu-positive gastric cancer
by: A. V. Avgustinovich, et al.
Published: (2024-03-01) -
Comparative evaluation of the prognostic significance of molecular tumor markers (estrogen and progesterone receptors, HER-2/neu) and the Nottingham prognostic index in breast cancer
by: V. Sekhri, et al.
Published: (2024-02-01) -
Expression of Human Epidermal Growth Factor Receptor (HER2/neu) and Proliferative Marker Ki-67 in Nonneoplastic, Preneoplastic, Neoplastic Lesions of Gallbladder and Its Association with Clinicopathological Parameters
by: Kiran Yadav, et al.
Published: (2025-01-01)